Chemical epigenetic modulators

Show results for

Unknown (52)
Genomics (16)
Transcriptomics (11)
Proteomics (5)
Metabolomics (1)

Organisms

Homo sapiens (12)
Mus musculus (6)
Alphavirus (3)
Anemia (3)
Betaherpesvirinae (3)
Borrelia (3)
Cowpox virus (3)
Coxsackievirus (3)
Cytomegalovirus (3)
Dengue virus (3)
EFO:0001352 (3)
Filoviridae (3)
Hepatitis B virus (3)
Human alphaherpesvirus 1 (3)
Human betaherpesvirus 5 (3)
Human immunodeficiency virus (3)
Human immunodeficiency virus 1 (3)
Human immunodeficiency virus 2 (3)
Influenza A virus (3)
Influenza C virus (3)
Japanese encephalitis virus group (3)
Lyssavirus rabies (3)
Middle East respiratory syndrome-related coronavirus (3)
Monkeypox virus (3)
Orthopoxvirus (3)
Orthopoxvirus vaccinia (3)
Rattus (3)
Staphylococcus aureus (3)
Streptococcus pneumoniae (3)
Viruses (3)

Organisms

Homo sapiens (5)
Mus musculus (3)

Repository

biostudies-arrayexpress (10)
ENA (9)
geo (8)
pride (3)
MassIVE (2)
GNPS (1)

Tissue

Brain (2)
Erythrocyte (1)

Disease

Lymphoma (1)

Technology Type

Mass Spectrometry (3)
Bottom-up proteomics (2)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Xevo G2-XS QTof (2)
NextSeq 500 (1)
TimsTOF HT (1)

Publication Date

2014 (8)
2023 (4)
2026 (3)
2024 (3)
2022 (2)
2021 (1)
2015 (1)
2017 (1)
2025 (1)

First Public Date

2024 (2)
2023 (2)
2022 (2)
2026 (1)
2025 (1)
2017 (1)

Study type

ChIP-seq (4)
RNA-seq of coding RNA (4)
ATAC-seq (1)
RNA-seq of non coding RNA (1)

Release Date

2014 (9)
2021 (8)
2015 (6)
2023 (6)
2020 (6)
2022 (5)
2025 (4)
2017 (4)
2024 (3)
2019 (2)
2018 (2)
2013 (2)
2016 (1)
2012 (1)
2011 (1)
2010 (1)
2009 (1)

Lab affiliation

The Drug Discovery Lab, Mary S. Easton Center for Alzheimer’s Disease Research, Department of Neurology, David Geffen School of Medicine, 710 Westwood Plaza, University of California Los Angeles, Los Angeles, CA 90095, USA (2)
Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt am Main, Germany (1)

Tags

xref:PubMed:34520746 (2)
xref:PubMed:29066820 (1)

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

Hypoxylon investiens extracts obtained by Plackett Burman DOE, using epigenetic modulators

Hypoxylon investiens (isolated from Asparagopsis taxiformis) extracts obtained by Plackett Burman DOE, using epigenetic modulators and varying physico-chemical conditions

ORGANISM(S): Hypoxylon Investiens (ncbitaxon:326663)

2023-11-28 | MSV000093521 | MassIVE

Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Not available

S-EPMC5581715 | biostudies-literature

GNPS - Hypoxylon investiens extracts obtained by Plackett Burman DOE, using epigenetic modulators

Hypoxylon investiens (endophytic fungi isolated from Asparagopsis taxiformis) extracts obtained by Plackett Burman DOE, using epigenetic modulators and varying physico-chemical conditions

ORGANISM(S): Hypoxylon Investiens (ncbitaxon:326663)

2023-11-28 | MSV000093521 | GNPS

Chem-CRISPR/dCas9FCPF - A platform for chemically induced epigenome editing

Epigenetic aberration is one of the major driving factors in human cancer, often leading to acquired resistance to chemotherapies. Various chemical epigenetic modulators have been reported. Nonetheless, outcomes from animal models and clinical trials have underscored the substantial setbacks attribu...

ORGANISM(S): Homo sapiens (Human)

2025-05-06 | PXD048673 | Pride